These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30138038)

  • 1. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.
    Li J; Ying Y; Xie H; Jin K; Yan H; Wang S; Xu M; Xu X; Wang X; Yang K; Zheng X; Xie L
    FASEB J; 2019 Jan; 33(1):1374-1388. PubMed ID: 30138038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.
    Li J; Xu X; Meng S; Liang Z; Wang X; Xu M; Wang S; Li S; Zhu Y; Xie B; Lin Y; Zheng X; Liu B; Xie L
    Cell Death Dis; 2017 Aug; 8(8):e3010. PubMed ID: 28837140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling.
    Xu X; Zhu Y; Liang Z; Li S; Xu X; Wang X; Wu J; Hu Z; Meng S; Liu B; Qin J; Xie L; Zheng X
    Cell Death Dis; 2016 Feb; 7(2):e2088. PubMed ID: 26844702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
    Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
    Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
    Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
    Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
    J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
    Yan H; Ren S; Lin Q; Yu Y; Chen C; Hua X; Jin H; Lu Y; Zhang H; Xie Q; Huang C; Huang H
    FASEB J; 2019 Nov; 33(11):12112-12123. PubMed ID: 31373842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis.
    Tan S; Kang Y; Li H; He HQ; Zheng L; Wu SQ; Ai K; Zhang L; Xu R; Zhang XZ; Zhao XK; Zhu X
    Cell Death Dis; 2021 Feb; 12(2):168. PubMed ID: 33568625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
    Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W
    Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
    Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.
    An N; Zheng B
    Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6.
    Wang X; Wu J; Lin Y; Zhu Y; Xu X; Xu X; Liang Z; Li S; Hu Z; Zheng X; Xie L
    J Exp Clin Cancer Res; 2014 Sep; 33(1):69. PubMed ID: 25178497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
    J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
    Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer.
    Liu P; Wu L; Chand H; Li C; Hu X; Li Y
    Life Sci; 2020 Nov; 261():118311. PubMed ID: 32861793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.
    Xu M; Li J; Wang X; Meng S; Shen J; Wang S; Xu X; Xie B; Liu B; Xie L
    Cell Death Dis; 2018 Feb; 9(2):209. PubMed ID: 29434190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
    Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
    FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.